Showing results (551-560 of 2,463) with videos related to
Sort By:
Pageof 247
Cancer Treatment Reviews|December 16, 2025
Sequencing antibody-drug conjugates in metastatic breast cancer: A systematic reviewLuiz F Costa de Almeida, Luís Felipe Leite, Anelise Poluboiarinov Cappellaro, et al.Cancer Treatment Reviews|December 12, 2025
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysisAlicia Escudero, Meritxell Bellet, Cristina Saura, et al.Cancer Treatment Reviews|July 1, 2025
Systematic literature review of intravenous versus subcutaneous administration of oncology therapies: A clinical, economic and patient perspectiveSaby George, Maria T Bourlon, Michael J Overman, et al.Cancer Treatment Reviews|July 18, 2025
Palliative systemic therapy for locally advanced or metastatic salivary duct carcinoma: A comprehensive reviewMasafumi Kanno, Satoshi Kano, Yoshinori Imamura, et al.Cancer Treatment Reviews|July 30, 2025
Tepotinib in patients with MET exon 14 skipping non-small cell lung cancerPaul K Paik, Wade T Iams, Hatim Husain, et al.Cancer Treatment Reviews|July 25, 2025
Exercise in patients with metastatic prostate cancer: A comprehensive reviewF Javier Muñoz-Carrillo, Marta Garcia de Herreros, David Carrillo, et al.Cancer Treatment Reviews|June 4, 2025
Medical management of pancreatic cancer: from personalization to broadening treatment strategiesNelson Dusetti, Jean Baptiste Bachet, Brice Chanez, et al.Cancer Treatment Reviews|August 15, 2025
Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapyXiaoxiao Xu, Tong Yu, Zhenxing WangCancer Treatment Reviews|February 7, 2026
Integrating antibody-drug conjugates into the management of early breast cancerMaria Ibáñez Alda, Thomas Grinda, Barbara PistilliCancer Treatment Reviews|June 10, 2025
Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysisYe Yuan, Xin Long, Mengya Wei, et al.Pageof 247